InvestSMART

Australian Pharmaceutical Industries Limited (ASX: API) - Announcements

DELISTED - Current share price for API : $1.530

ASX company news and announcements for Australian Pharmaceutical Industries Limited (API) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Pharmaceutical Industries Limited (API) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Pharmaceutical Industries Limited (API), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Pharmaceutical Industries Limited (API)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice 31 Jan 2019 4:29PM $1.260 $1.530 risen by 21.43%
- MDC: Medlab Expands Nutraceutical Range to 2,100 Pharmacies 30 Jan 2019 9:36AM $1.315 $1.530 risen by 16.35%
- API - Change in Company Office Holders 29 Jan 2019 12:40PM $1.335 $1.530 risen by 14.61%
- Change of Director's Interest Notice 29 Jan 2019 12:34PM $1.335 $1.530 risen by 14.61%
- 2018 AGM - Results of Meeting 23 Jan 2019 3:43PM $1.480 $1.530 risen by 3.38%
- 2018 AGM - CEO Address to Shareholders 23 Jan 2019 1:38PM $1.493 $1.530 risen by 2.51%
- 2018 AGM - Chair's Address to Shareholders 23 Jan 2019 1:36PM $1.493 $1.530 risen by 2.51%
- 2018 AGM - Presentation to Shareholders 23 Jan 2019 1:32PM $1.493 $1.530 risen by 2.51%
- API - 2018 AGM arrangements 16 Jan 2019 9:35AM $1.380 $1.530 risen by 10.87%
- Becoming a substantial holder 21 Dec 2018 9:32AM $1.375 $1.530 risen by 11.27%
- Change of Director's Interest Notice 19 Dec 2018 9:38AM $1.400 $1.530 risen by 9.29%
- Change of Director's Interest Notice 19 Dec 2018 9:34AM $1.400 $1.530 risen by 9.29%
- SIG: Company Update 14 Dec 2018 11:51AM $1.555 $1.530 fallen by 1.61%
- API merger proposal investor briefing 14 Dec 2018 9:50AM $1.470 $1.530 risen by 4.08%
- API merger proposal presentation 14 Dec 2018 9:49AM $1.470 $1.530 risen by 4.08%
- API announces merger proposal with Sigma 14 Dec 2018 9:47AM $1.470 $1.530 risen by 4.08%
- Becoming a substantial holder for SIG 14 Dec 2018 9:33AM $1.470 $1.530 risen by 4.08%
- Appendix 4G - Key to Disclosures 7 Dec 2018 8:45AM $1.455 $1.530 risen by 5.15%
- API 2018 Corporate Governance Statement 7 Dec 2018 8:40AM $1.455 $1.530 risen by 5.15%
- Proxy Form - 2018 Annual General Meeting 7 Dec 2018 8:36AM $1.455 $1.530 risen by 5.15%
- Notice of 2018 Annual General Meeting 7 Dec 2018 8:34AM $1.455 $1.530 risen by 5.15%
- 2018 Annual Report to Shareholders 7 Dec 2018 8:32AM $1.455 $1.530 risen by 5.15%
- Letter to Shareholders - 2018 Annual General Meeting 7 Dec 2018 8:28AM $1.455 $1.530 risen by 5.15%
- Letter to Shareholders - Final Dividend Payment 7 Dec 2018 8:27AM $1.455 $1.530 risen by 5.15%
- Change of Director's Interest Notice 12 Nov 2018 10:22AM $1.575 $1.530 fallen by 2.86%

201 - 225 of 477 results

Page 9 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.